ScholarGate
Asistents

Salīdzināt metodes

Apskatiet izvēlētās metodes blakus; rindas, kas atšķiras, ir izceltas.

Gastroparesis Cardinal Symptom Index×Short Inflammatory Bowel Disease Questionnaire×
NozareGastroenteroloģijaGastroenteroloģija
SaimeProcess / pipelineProcess / pipeline
Izcelsmes gads20032004
AutorsRevicki, D. A., Rentz, A. M., Dubois, D., et al.Guyonnet, D., Chassany, O., Ducroc, R., et al.
TipsSelf-reportSelf-report
PirmavotsRevicki, D. A., Rentz, A. M., Dubois, D., Kahrilas, P., Stanghellini, V., Talley, N. J., & Tack, J. (2003). Development and validation of a patient-assessed gastroparesis symptom severity index. Alimentary Pharmacology & Therapeutics, 18(1), 141–150. link ↗Guyonnet, D., Chassany, O., Ducroc, R., Picard, C., Mouret, M., D'Haens, G., & Svartz, H. (2004). Effect of fermented milk containing Bifidobacterium animalis DN-173 010 on the health-related quality of life and symptoms in irritable bowel syndrome in adults in France: A multicentre, randomized, double-blind, controlled trial. Alimentary Pharmacology & Therapeutics, 20(4), 459–465. link ↗
Citi nosaukumiGCSIIBDQ-32, Short IBDQ
Saistītās44
KopsavilkumsThe Gastroparesis Cardinal Symptom Index (GCSI) is a validated, patient-reported outcome measure specifically designed to assess symptom severity in gastroparesis. Developed by Revicki and colleagues in 2003, the GCSI captures the three cardinal symptom clusters of gastroparesis: nausea and vomiting, postprandial fullness, and early satiety, plus bloating and stomach distension. The 9-item questionnaire is responsive to treatment changes and is increasingly used in clinical trials and practice to monitor gastroparesis progression and therapy response.The Short Inflammatory Bowel Disease Questionnaire (IBDQ-32) is a validated patient-reported outcome measure designed to assess the impact of inflammatory bowel disease (IBD)—both ulcerative colitis and Crohn's disease—on health-related quality of life. Derived from the original 32-item IBDQ, this instrument comprises four domains: Bowel Symptoms, Systemic Symptoms, Social Function, and Emotional Function. The IBDQ-32 is responsive to treatment and is increasingly used in IBD clinical trials and practice.
ScholarGateDatu kopa
  1. v1
  2. 1 Avoti
  3. PUBLISHED
  1. v1
  2. 1 Avoti
  3. PUBLISHED

Doties uz meklēšanu Lejupielādēt slaidus

ScholarGateSalīdzināt metodes: Gastroparesis Cardinal Symptom Index · Short Inflammatory Bowel Disease Questionnaire. Izgūts 2026-06-20 no https://scholargate.app/lv/compare